COURTNEY MILLESON: Open Payments
NPI 1588333447 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 24 payments from 10 companies in 2025. Trend: 2023 $272 · 2024 $292 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $201 |
| Madrigal Pharmaceuticals | 2 | $112 |
| PFIZER INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Janssen Biotech, Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: REZDIFFRA, RINVOQ, MAVYRET, XIFAXAN, XELJANZ, TREMFYA, IBSRELA, EOHILIA.
Industry payments across NC — which companies pay providers there.
